Gilead Sciences, Panera Bread, Apple: Stock Market Movers

Bloomberg Technology 2015-10-29

Views 0

Oct. 28 -- Bloomberg’s Abigail Doolittle examines the stocks on the move at the start of today's trade at the Nasdaq. She speaks on "Bloomberg ‹GO›."
Show more

Share This Video


Download

  
Report form
RELATED VIDEOS
Morning Stock Movers: Verizon Communications Inc (NYSE: VZ), Apple Inc (NASDAQ: AAPL)
play
00:42

Morning Stock Movers: Verizon Communications Inc (NYSE: VZ), Apple Inc (NASDAQ: AAPL)
Gilead Sciences, Pharmactive İlaç ile yerli üretim anlaşması imzaladı (2) - İSTANBUL
play
05:36

Gilead Sciences, Pharmactive İlaç ile yerli üretim anlaşması imzaladı (2) - İSTANBUL
Gilead Sciences Inc’s antiviral remdesivir could be priced up to $5,080 per course
play
03:10

Gilead Sciences Inc’s antiviral remdesivir could be priced up to $5,080 per course
Ricerca, premiati a Milano i vincitori della 13esima edizione dei Bandi di Gilead Sciences
play
03:20

Ricerca, premiati a Milano i vincitori della 13esima edizione dei Bandi di Gilead Sciences
(GILD) Gilead Sciences, Inc.
play
05:30

(GILD) Gilead Sciences, Inc.
Al via la campagna di sensibilizzazione ‘Hiv. Ne parliamo?’ di Gilead Sciences
play
02:29

Al via la campagna di sensibilizzazione ‘Hiv. Ne parliamo?’ di Gilead Sciences
Aids, Da Silva (Gilead Sciences):
play
01:22

Aids, Da Silva (Gilead Sciences): "Molti progressi, ma c’è tanta disinformazione"
Scores Equity GPS: la valeur Gilead Sciences rafle un 10 sur 10: Gilles Bazy-Sire, dans Intégrale Bourse – 19/08
play
07:53

Scores Equity GPS: la valeur Gilead Sciences rafle un 10 sur 10: Gilles Bazy-Sire, dans Intégrale Bourse – 19/08
Gilead Sciences Could Catapult This Company To Profitability
play
06:19

Gilead Sciences Could Catapult This Company To Profitability
U.S. FDA gives full approval to Gilead Sciences' antivirul drug Remdesivir as COVID-19 treatment
play
02:22

U.S. FDA gives full approval to Gilead Sciences' antivirul drug Remdesivir as COVID-19 treatment
U.S. FDA gives full approval to Gilead Sciences' antivirul drug Remdesivir as COVID-19 treatment
play
00:35

U.S. FDA gives full approval to Gilead Sciences' antivirul drug Remdesivir as COVID-19 treatment
Tumore, da Silva (Gilead Sciences):
play
00:52

Tumore, da Silva (Gilead Sciences): "Onorati di essere al fianco di Aiom"